Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prolonged Periods

Malaria remains a major public health concern, particularly in tropical and subtropical regions, affecting hundreds of millions of people worldwide. Antimalarial drugs have been instrumental in reducing the burden of malaria, but their long-term health effects have raised concerns among healthcare professionals and policymakers.

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis

5 out of 5

FREE

Types of Antimalarial Drugs and Their Mechanisms

Artemisinin-based combination therapies (ACTs) are the first-line treatment for uncomplicated malaria. ACTs combine artemisinin, a rapidly acting blood schizonticide, with a partner drug to prevent resistance. Other commonly used antimalarial drugs include chloroquine, sulfadoxine-pyrimethamine, and mefloquine.

Potential Long-Term Health Effects

Cardiotoxicity: Mefloquine has been associated with rare but potentially fatal cardiac arrhythmias, particularly in patients with pre-existing cardiac conditions. The risk of cardiotoxicity is highest within the first few weeks of treatment.

Neurological Effects: Mefloquine can cause a range of neurological symptoms, including dizziness, tinnitus, anxiety, insomnia, and hallucinations. These effects typically resolve after discontinuation of the drug, but some cases have reported persistent symptoms.

Hepatotoxicity: Chloroquine and sulfadoxine-pyrimethamine can cause liver damage, particularly in patients with pre-existing liver conditions. The risk of hepatotoxicity is generally low, but it can be fatal in severe cases.

Hematological Effects: Sulfadoxine-pyrimethamine can cause anemia and thrombocytopenia, particularly in patients with glucose-6-phosphate dehydrogenase deficiency. These effects are usually mild and reversible, but they can be more severe in patients with underlying hematological conditions.

Balancing Risks and Benefits

The potential long-term health effects of antimalarial drugs must be carefully weighed against their benefits in preventing malaria. Malaria is a deadly disease, and ACTs have significantly reduced mortality and morbidity. However, the potential risks of long-term use should be considered, particularly in patients with pre-existing medical conditions.

Implications for Global Health

The assessment of long-term health effects of antimalarial drugs has important implications for global health. Healthcare professionals must be aware of the potential risks and benefits of these drugs to make informed prescribing decisions. Policymakers should consider the need for surveillance systems to monitor long-term health outcomes in patients using antimalarial drugs.

Antimalarial drugs have played a crucial role in reducing the burden of malaria, but their long-term health effects are a growing concern. The potential risks of cardiotoxicity, neurological effects, hepatotoxicity, and hematological effects must be carefully considered when prescribing these drugs. Balancing the benefits of preventing malaria with the potential long-term health risks is essential for optimizing patient care and protecting global health.

References

• World Health Organization. (2022). Guidelines for the treatment of malaria. Retrieved from https://www.who.int/publications/i/item/9789240045166
• Centers for Disease Control and Prevention. (2022). Antimalarial drugs. Retrieved from https://www.cdc.gov/malaria/resources/pdf/malaria_drugs.pdf
• National Institute of Health. (2022). Long-term effects of antimalarial drugs. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092211/

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis

5 out of 5

FREE